GlassScriptPhysician profile
David Neil Morris
NPI 1265430979
$4,598.49
in general payments reported to CMS, 2019-2025
9 companies · $2,038 in 2025
The $2,038 reported for 2025 was more than what 87% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $29.47 · 2021: $93.21 · 2022: $579 · 2023: $971 · 2024: $769 · 2025: $2,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,177 · Education: $402 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,176.68 |
| Education | $401.97 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,335.17 | 2020-2025 | Wakix |
| Inspire Medical Systems, INC. | $1,244.68 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $837.66 | 2019-2025 | |
| Axsome Therapeutics, INC. | $590.76 | 2022-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $505.41 | 2025 | Lumryz |
| Philips North America LLC | $33.02 | 2019-2021 | |
| Lilly USA, LLC | $19.06 | 2025 | Zepbound |
| Resmed Corp | $18.57 | 2024 | |
| Fisher & Paykel Healthcare INC | $14.16 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.